Journal
FOODS
Volume 10, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/foods10071580
Keywords
obesity; synbiotics; Lactobacillus; Bifidobacterium; inulin; fructooligosaccharide
Categories
Funding
- Research and Innovation Fund for Small Scale Enterprise (RISE) [RDG62I0007]
- Research and Researcher Development for Industry Program (RRi) of the Thailand Research Fund (TRF) [PHD60I0022]
- Chiang Mai University
Ask authors/readers for more resources
The cluster of metabolic disorders such as obesity, dyslipidemia, hypertension, and glucose intolerance increases the risk of developing cardiovascular diseases and type 2 diabetes. Research suggests a crucial role of microbiota in human health and disease, influencing digestion, energy and glucose metabolism, immunomodulation, and brain function. Supplementation of synbiotics significantly alters obesity-associated biomarkers, opening avenues for further studies to explore their potential in managing obesity-related health issues.
The cluster of metabolic disorders includes obesity, dyslipidemia, hypertension, and glucose intolerance, increasing the risk of developing cardiovascular diseases and type 2 diabetes. Evolving proofs suggest an essential role of microbiota in human health and disease, including digestion, energy and glucose metabolism, immunomodulation, and brain function. The frequency of overweight is increasing, and the main causes for this are highly processed foods and less active lifestyles. Research is underway to unravel the probable relationship between obesity and intestinal microbiota. Here, we propose a method to understand and elucidate the synergistic function of prebiotics and probiotics in treating obesity. The biomarkers of obesity, such as cholesterol, gut permeability, oxidative stress, bacterial toxins, cytokines, and short-chain fatty acids, were analyzed in Thai obese individuals after being supplemented with a synbiotic preparation containing Lactobacillus paracasei, Bifidobacterium longum, Bifidobacterium breve, inulin, and fructooligosaccharide. The results reveal that the supplementation of synbiotics significantly altered the obesity-associated biomarkers in an appositive way. Further studies are warranted to use synbiotics as an adjuvant therapy for the management of obesity-related health issues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available